Mental health and HIV PrEP study
Part of Mental health clinical trials.
This study looks at how mental health relates to using PrEP, the medicine that prevents HIV. It aims to help improve care for people taking PrEP.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must be taking PrEP for HIV prevention at one of the participating clinics.
- You must have French social security coverage.
- You must be able to read and understand French well enough to fill out questionnaires.
- You must not be currently being treated for HIV (this study is only for people taking PrEP, not for HIV).
- This must not be your very first visit for PrEP.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help men who have sex with men improve their mental health and decide if they want to take PrEP, a pill that prevents HIV. It is for men who are feeling some anxiety or depression but are not currently taking PrEP.
This study tries to reduce the psychological barriers that make it hard for pregnant or postpartum women to keep taking PrEP. It may help by offering support tailored to stress, trauma symptoms, or depression—especially soon after PrEP is started.
This study tests whether a counseling program helps healthcare providers better support patients who could benefit from PrEP (medicine that prevents HIV). It looks at how well providers identify and discuss PrEP with patients.
This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.
This study tests a program that helps people with HIV manage depression and stick to their treatment. It's for adults in Cape Town, South Africa, who have a detectable HIV viral load or may have one, and who show signs of depression.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
Hear when a new Major Depressive Disorder in Patients Taking PrEP trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.